Goldman Sachs
HIMS icon

Goldman Sachs’s Hims & Hers Health HIMS Stock Holding History

Goldman Sachs’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.58M Sell
124,500
-475,500
-79% -$11.2M ﹤0.01% 4306
2025
Q4 		$19.5M Buy
600,000
+343,600
+134% +$14.7M ﹤0.01% 2400
2025
Q3 		$14.5M Buy
256,400
+49,500
+24% +$2.54M ﹤0.01% 2589
2025
Q2 		$10.3M Buy
206,900
+84,900
+70% +$3.84M ﹤0.01% 2729
2025
Q1 		$3.61M Buy
122,000
+22,000
+22% +$817K ﹤0.01% 3663
2024
Q4 		$2.42M Buy
+100,000
New +$2.48M ﹤0.01% 4119
2021
Q4 		– Sell
-450,000
Closed -$3.39M – 6553
2021
Q3 		$3.39M Buy
+450,000
New +$3.81M ﹤0.01% 3699

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs's HIMS Position: Q1 2026 in Review

Goldman Sachs reduced its Hims & Hers Health (HIMS) stake by 76% in Q1 2026, selling an estimated $186M and leaving 2,454,695 shares worth $51M. The position accounts for 0.01% of the portfolio, ranked #1568.

Goldman Sachs first reported a position in HIMS in Q1 2021 and has held it in 21 quarters since. The position peaked at $523M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Goldman Sachs held 2,454,695 shares of Hims & Hers Health worth $51M as of Q1 2026.
  • Goldman Sachs sold 7,892,648 Hims & Hers Health shares in Q1 2026, an estimated $186M.
  • Hims & Hers Health made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1568 holding.
  • Goldman Sachs first reported a position in Hims & Hers Health in Q1 2021 and has held it in 21 quarters since.
  • Goldman Sachs's Hims & Hers Health position peaked at $523M in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.